Connecting the speckles: Splicing kinases and their role in tumorigenesis and treatment response

56Citations
Citations of this article
139Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abbreviations: SR, serine arginine; SRPK, serine arginine protein kinase; CLK, CDC-like kinase; PRP4K, pre-mRNA processing factor 4 kinase; snRNP, small nuclear ribonucleic protein. Alternative pre-mRNA splicing in higher eukaryotes enhances transcriptome complexity and proteome diversity. Its regulation is mediated by a complex RNA-protein network that is essential for the maintenance of cellular and tissue homeostasis. Disruptions to this regulatory network underlie a host of human diseases and contribute to cancer development and progression. The splicing kinases are an important family of pre-mRNA splicing regulators, , which includes the CDC-like kinases (CLKs), the SRSF protein kinases (SRPKs) and pre-mRNA splicing 4 kinase (PRP4K/PRPF4B). These splicing kinases regulate pre-mRNA splicing via phosphorylation of spliceosomal components and serine- arginine (SR) proteins, affecting both their nuclear localization within nuclear speckle domains as well as their nucleocytoplasmic shuttling. Here we summarize the emerging evidence that splicing kinases are dysregulated in cancer and play important roles in both tumorigenesis as well as therapeutic response to radiation and chemotherapy.

Cite

CITATION STYLE

APA

Corkery, D. P., Holly, A. C., Lahsaee, S., & Dellaire, G. (2015). Connecting the speckles: Splicing kinases and their role in tumorigenesis and treatment response. Nucleus, 6(4), 279–288. https://doi.org/10.1080/19491034.2015.1062194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free